Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    September 2017
  1. REZNIK E, Smith AW, Taube S, Mann J, et al
    Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
    Am J Clin Oncol. 2017 Sep 12. doi: 10.1097/COC.0000000000000406.
    PubMed     Text format     Abstract available


    August 2017
  2. BURRI SH, Gondi V, Brown PD, Mehta MP, et al
    The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Am J Clin Oncol. 2017 Aug 24. doi: 10.1097/COC.0000000000000395.
    PubMed     Text format     Abstract available


    June 2017
  3. ELLSWORTH S, Ye X, Grossman SA
    Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Am J Clin Oncol. 2017;40:219-222.
    PubMed     Text format     Abstract available


  4. BOXERMAN JL, Ellingson BM, Jeyapalan S, Elinzano H, et al
    Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
    Am J Clin Oncol. 2017;40:228-234.
    PubMed     Text format     Abstract available


  5. GHOSE A, Guha G, Kundu R, Tew J, et al
    CNS Hemangiopericytoma: A Systematic Review of 523 Patients.
    Am J Clin Oncol. 2017;40:223-227.
    PubMed     Text format     Abstract available


    March 2017
  6. MCTYRE E, Lucas JT, Helis C, Farris M, et al
    Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000380.
    PubMed     Text format     Abstract available


  7. ZHANG C, Verma V, Lyden ER, Horowitz DP, et al
    The Role of Definitive Radiotherapy in Craniopharyngioma: A SEER Analysis.
    Am J Clin Oncol. 2017 Mar 3. doi: 10.1097/COC.0000000000000378.
    PubMed     Text format     Abstract available


    February 2017
  8. MILANO MT, Grossman CE
    Meningioma in Breast Cancer Patients: Population-based Analysis of Clinicopathologic Characteristics.
    Am J Clin Oncol. 2017;40:11-16.
    PubMed     Text format     Abstract available


    September 2016
  9. MOOTS PL, O'Neill A, Londer H, Mehta M, et al
    Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  10. GARRETT MD, Wu CC, Yanagihara TK, Jani A, et al
    Radiation Therapy for the Management of Brain Metastases.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  11. BOYCHAK A, Bauman G, Fisher B, Abdulkarim B, et al
    A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life.
    Am J Clin Oncol. 2016;39:160-6.
    PubMed     Text format     Abstract available


    February 2016
  12. SCHEICK S, Amdur RJ, Kirwan JM, Morris CG, et al
    Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.
    Am J Clin Oncol. 2016;39:49-54.
    PubMed     Text format     Abstract available


    January 2016
  13. WILLIAMS NL, Rotondo RL, Bradley JA, Pincus DW, et al
    Late Effects After Radiotherapy for Childhood Low-grade Glioma.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  14. ELINZANO H, Glantz M, Mrugala M, Kesari S, et al
    PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  15. SETHI RA, Rush SC, Liu S, Sethi SA, et al
    Dose-Response Relationships for Meningioma Radiosurgery.
    Am J Clin Oncol. 2015;38:600-4.
    PubMed     Text format     Abstract available


  16. SAAD S, Wang TJ
    Neurocognitive Deficits After Radiation Therapy for Brain Malignancies.
    Am J Clin Oncol. 2015;38:634-40.
    PubMed     Text format     Abstract available


    September 2015
  17. WAQAR SN, Waqar SH, Trinkaus K, Gadea CA, et al
    Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  18. CHOI Y, Lim DH, Yu JI, Jo K, et al
    Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  19. CARAVATTA L, Deodato F, Ferro M, Macchia G, et al
    Results of a Phase II Study of Short-Course Accelerated Radiation Therapy (SHARON) for Multiple Brain Metastases.
    Am J Clin Oncol. 2015;38:395-400.
    PubMed     Text format     Abstract available


    June 2015
  20. SADRAEI NH, Dahiya S, Chao ST, Murphy ES, et al
    Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
    Am J Clin Oncol. 2015;38:304-10.
    PubMed     Text format     Abstract available


    May 2015
  21. PUTZ F, Knippen S, Lahmer G, Fietkau R, et al
    A Model to Predict the Feasibility of Concurrent Chemoradiotherapy With Temozolomide in Glioblastoma Multiforme Patients Over Age 65.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  22. PATEL KR, Shoukat S, Oliver DE, Chowdhary M, et al
    Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  23. XIE H, Ahluwalia MS, Peereboom DM
    The Cleveland Clinic experience with primary central nervous system lymphoma.
    Am J Clin Oncol. 2015;38:140-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: